ArticleFrontiers in oncology2022

Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling.

Li-Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.